First Wave BioPharma
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell FWBI and other ETFs, options, and stocks.About FWBI
First Wave Biopharma, Inc. is a clinical stage biopharmaceutical company, which engages in the research and development of non-systemic therapies for the treatment of gastrointestinal diseases. The firm is involved in a therapeutic development pipeline populated with multiple clinical stage programs built around its proprietary technologies, such as Niclosamide, an oral small molecule with anti-viral and anti-inflammatory properties, and the biologic Adrulipase, a recombinant lipase enzyme designed to enable the digestion of fats and other nutrients.
CEOJames E. Sapirstein
CEOJames E. Sapirstein
Employees9
Employees9
HeadquartersBoca Raton, Florida
HeadquartersBoca Raton, Florida
Founded2014
Founded2014
Employees9
Employees9
FWBI Key Statistics
Market cap5.65M
Market cap5.65M
Price-Earnings ratio-0.03
Price-Earnings ratio-0.03
Dividend yield—
Dividend yield—
Average volume40.39K
Average volume40.39K
High today$2.83
High today$2.83
Low today$2.69
Low today$2.69
Open price$2.70
Open price$2.70
Volume17.67K
Volume17.67K
52 Week high$62.40
52 Week high$62.40
52 Week low$2.33
52 Week low$2.33